Security key
15673T100
Century Therapeutics, Inc. - Common Stock, par value $0.0001 per share (IPSC)
CUSIP: 15673T100
Q1 2026 13F Holders as of 31 Mar 2026
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Total 13F shares
- 138,751,378
- Total 13F value
- $312,461,788
- Share change
- +108,718,791
- SEC-reported price per share
- $2.26
- Number of holders
- 72
- Value change
- +$246,781,720
- Number of buys
- 45
- Number of sells
- 16
- Shares outstanding
- 180,747,818
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2026
Institutions
72
Top holders
10
IPSC full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
Previous quarter: Q4 2025
Century Therapeutics, Inc. SEC filings
Century Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 15673T100
Recent filing periods:
Ownership snapshot
Top reported holders of IPSC - Century Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
RA CAPITAL MANAGEMENT, L.P.
Disclosed value leader
RTW INVESTMENTS, LP
Comparable rows
15/15
Latest evidence
31 Mar 2026
13D/G
13F
Lead comparable stake: 9.9%
13D/G row: RA CAPITAL MANAGEMENT, L.P.
Showing 1-6 of 15 holder rows.
Quick read
RA CAPITAL MANAGEMENT, L.P. leads the comparable SEC ownership view at 9.9%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens RA CAPITAL MANAGEMENT, L.P.'s linked filing trail.
Comparable ownership
Top 5
RA CAPITAL MANAGEMENT, L.P.
9.9%
TCG Crossover GP II, LLC
9.9%
Deep Track Capital, LP
7.3%
RTW INVESTMENTS, LP
7.1%
Commodore Capital LP
7.1%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. |
13D/G
|
9.9%
|
$16,997,172
17,944,649 shares
|
$0 | 09 Jan 2026 |
| TCG Crossover GP II, LLC |
13D/G
Chen Yu
|
9.9%
|
$15,978,987
17,754,430 shares
|
$0 | 09 Jan 2026 |
| Deep Track Capital, LP |
13D/G
|
7.3%
|
$12,137,760
13,486,400 shares
|
$0 | 08 Jan 2026 |
| RTW INVESTMENTS, LP |
13D/G
|
7.1%
|
$29,608,695
13,043,478 shares
|
$0 | 31 Mar 2026 |
| Commodore Capital LP |
13D/G
|
7.1%
|
$12,354,782
13,043,478 shares
|
$0 | 09 Jan 2026 |
| Venrock Healthcare Capital Partners III, L.P. |
13D/G
|
7.1%
|
$12,354,782
13,043,478 shares
|
+$8,606,536 | 09 Jan 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
72
Shares
138,751,378
Rows available
72
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2026 vs Q4 2025 Across Filers
Q4 2025 holders
46
Q1 2026 holders
72
Holder diff
26
| Investor | Q4 2025 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q4 2025 value | Q1 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend